Skip to content
zameds

Medroxyprogesterone

Sold as Omrastoz, Mensera, Sayana, Mytricon, Medroxyprogesterone mylan, Triclogyn, Medroxyprogesterone AURO, Prigauro, Medroxyprogesterone acetate rx medicals, Depo-provera, Provera, Petogen

S4
Loading the molecular structure
C24H34O4386.50 g/mol

[(6S,8R,9S,10R,13S,14S,17R)-17-Acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate

Drag to rotate. Structure from PubChem CID 6279.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
10
Registrations
17
Schedule source
Consolidated Schedules 06 July 2026

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Pharmacare limited û woodmeadOmrastoz150 mg280202S4None
Trinity Pharma (Pty) LtdMensera5, 10380188, 380189S4None
Pfizer Laboratories (Pty) LtdSayana, Depo-provera, Provera10, 100 mg, 104 mg/0,65 ml, 150 mg, 500 mg451139, E0114, S0001, W0462, Z0363S4PIPIL
Viatris Healthcare (Pty) LtdMytricon, Medroxyprogesterone mylan150 mg/ml520991, 520992.991S4PIPIL
Ascendis Pharma (Pty) LtdTriclogyn150 mg/ml560486S4None
Aurogen South Africa (Pty) LtdCertificate held by Aurogen SA (Pty) LtdMedroxyprogesterone AURO, Prigauro150 mg561072, 561073.1072S4PIPIL
Rx Medicals (Pty) LtdMedroxyprogesterone acetate rx medicalsNot stated590057S4None
Upjohn South Africa (Pty) LtdProvera100 MGG2987S4None
Pharmacia South Africa (Pty) LtdProvera5G2988S4None
Fresenius Kabi Manufacturing SA (Pty) LtdPetogenNot statedJ0278S4None

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Omrastoz 150 MG

EACH 1 ML AMPOULE CONTAINS MEDROXYPROGESTERONE ACETATE 150 MG

150 mg28020228/21.8.2/0202RegisteredS4None
Mensera 5

EACH TABLET CONTAINS MEDROXYPROGESTERONE ACETATE 5,0 mg

538018838/21.8.2/0188RegisteredS4None
Mensera 10

EACH TABLET CONTAINS MEDROXYPROGESTERONE ACETATE 10,0 mg

1038018938/21.8.2/0189RegisteredS4None
Sayana 104 mg/0,65 ML

EACH PRE-FILLED SYRINGE CONTAINS :MEDROXYPROGESTERONE ACETATE 104,0 mg

104 mg/0,65 ml45113945/21.8.2/1139RegisteredS4None
Mytricon150 mg/mlSuspension for injection.52099152/21.8.2/0991Approved 4 December 2024RegisteredS4PIPIL
Medroxyprogesterone mylan150 mg/mlSuspension for injection.520992.99152/21.8.2/0992.991Approved 4 December 2024RegisteredS4PIPIL
Triclogyn 150 mg/ml

EACH VIAL CONTAINS MEDROXYPROGESTERONE ACETATE 150,0 mg

150 mg/ml56048656/21.8.2/0486RegisteredS4None
Medroxyprogesterone AURO

Each 1,0 ml suspension contains: Medroxyprogesterone Acetate 150,0 mg

150 mgInjectable suspension56107256/21.8.2/1072Approved 10 June 2025RegisteredS4PIPIL
Prigauro

Each 1,0 ml suspension contains: Medroxyprogesterone Acetate 150,0 mg

150 mgInjectable suspension561073.107256/21.8.2/1073.1072Approved 10 June 2025RegisteredS4PIPIL
Medroxyprogesterone acetate rx medicals

EACH 1,0 ml SUSPENSION CONTAINS MEDROXYPROGESTERONE ACETATE 150,0 mg

Not listed59005759/21.8.2/0057RegisteredS4None
Depo-provera 150

EACH 1 ml CONTAINS MEDROXYPROGESTERONE ACETATE 150 mg

150 mgSuspension for injectionE0114E/21.8.2/114Approved 21 January 2025RegisteredS4PIPIL
Provera 100 MG

EACH TABLET CONTAINS MEDROXYPROGESTERONE ACETATE A 100 MG

100 MGG2987Old MedicineS4None
Provera 5

EACH TABLET CONTAINS MEDROXYPROGESTERONE ACETATE A 5,0 mg

5G2988Old MedicineS4None
Petogen

EACH 1 ml SOLUTION CONTAINS MEDROXYPROGESTERONE ACETATE 150 mg

Not listedJ0278J/21.8.2/278RegisteredS4None
Provera 100 MG

EACH TABLET CONTAINS MEDROXYPROGESTERONE ACETATE 100 mg

100 mgS0001S/21.8.2/1RegisteredS4None
Provera 500 MG

EACH TABLET CONTAINS MEDROXYPROGESTERONE ACETATE 500 mg

500 mgW0462W/21.8.2/462RegisteredS4None
Provera 10

EACH TABLET CONTAINS MEDROXYPROGESTERONE ACETATE 10,0 mg

10Z0363Z/21.8.2/363RegisteredS4None

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Medroxyprogesterone acetate

  • S4: Medroxyprogesterone

    Consolidated Schedules 06 July 2026, line 7019

Pharmacological class: Progesterones with or without oestrogens. (class 21.8.2)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Mytricon, Viatris Healthcare (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsMytricon, Viatris Healthcare (Pty) LtdPatient information leaflet (PIL)For patients and carersMytricon, Viatris Healthcare (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles